检索结果-南通市图书馆

Involvement of haptoglobin in disease development

World Journal of Hematology 2024年第2期11卷 1-7页

作者： Romaric Tuono De Manfouo JosuéSimo Louokdom Bernard claude Chetcha Larissa Michelle BakamMagoua Prosper Cabral Biapa Nya Constant Anatole Pieme claude tayou tagny Department of Microbiology ParasitologyHematologyand Infectious DiseasesHematology UnitFaculty of Medicine and Biomedical SciencesUniversity of Yaoundé1Yaoundé296Cameroon Higher Institute of Health Sciences Universitédes MontagnesBangangté296Cameroon Public Health and Biotechnology Research Laboratory(LAPHER-Biotech) Faculty of SciencesUniversity of Yaoundé1Yaoundé296Cameroon Faculty of Sciences Universitéde DschangDschang 296Cameroon Department of Biochemistry Faculty of Medicine and Biomedical SciencesUniversity of Yaoundé1Yaoundé296Cameroon

Haptoglobin(HP)is a liver glycoprotein that is actively synthesized during in-flammatory and hemolytic *** also has pro-oxidant and proinflam-matory properties,which are a function of its *** genetic polymorp-hism of the chains leads to synthesis of three phenotypes/proteins,which are related to the number and type of chains and their molecular weight,namely HP1-1,HP1-2 and *** with HP2-2 have more vascular complications,while those with HP1-1 have *** is involved in the worsening of diseases,such as HP2-2 in aggravation of vaso-occlusive crises in sickle cell disease,and worsening of the pathophysiology of other *** contrast,HP1-1 confers better protection against *** of this suggests that further studies should be conducted,including experimental and analytical studies focused on de-monstrating the influence of different HP genotypes on individual clinical and hematological *** would help in understanding the role played by this genetic polymorphism in the pathophysiology of diseases.

关键词： Haptoglobin Protein Properties Polymorphism Diseases

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Hematobiological Profile of Patients with Chronic Myeloid Leukemia at the Diagnosis in Yaoundé: A Cross-Sectional Study

引用

Open Journal of Blood Diseases 2020年第4期10卷 110-123页

作者： Annie Prudence Bisso Ngono Prisca Angandji Tipane Sylvain Raoul Simeni Njonnou Aimée Tiodoung Timnou Anne Juliette Flora Sango Paul Ndom claude tayou tagny Dora Mbanya Department of Microbiology Parasitology Hematology and Infectious Diseases Faculty of Medicine and Biomedical Sciences University of Yaoundé I Yaoundé Cameroon Yaoundé Central Hospital Yaoundé Cameroon Yaoundé Jamot’s Hospital Yaoundé Cameroon Department of Internal Medicine and Specialties Faculty of Medicine and Pharmaceutical Sciences University of Dschang Dschang Cameroon Dschang District Hospital Dschang Cameroon Department of Internal Medicine and Specialties Faculty of Medicine and Biomedical Sciences University of Yaoundé I Yaoundé Cameroon Department of Internal Medicine and Pediatrics Faculty of Health Sciences Medicine and Biomedical Sciences University of Buea Buea Cameroon Yaoundé General Hospital Yaoundé Cameroon Solidarité Chimiothérapie (SOCHIMIO) Yaoundé Cameroon Yaounde University Teaching Hospital Yaoundé Cameroon National Center for Blood Transfusion Yaoundé Cameroon

Background: Chronic Myeloid Leukemia (CML) is a myeloproliferative blood neoplasia, characterized by the presence of a translocation between chromosomes 9 and 22 leading to the formation of the Philadelphia chromosome. Data on the biological profile of patients with CML at diagnosis are still lacking in sub-Saharan Africa, particularly in Cameroon. Methods: A cross-sectional study was carried out from January 2001 to July 2016 among patients recently diagnosed with CML at the Yaounde University Teaching Hospital, the Yaoundé Central Hospital and the Yaoundé General Hospital. Analyzed variables included socio-demographic, clinical presentation, the diagnosis means, biological parameters (hematological and biochemical). Sampling was consecutive. Results: We included 132 (76 males) patients with CML with a median age of 39.2 years at diagnosis. The 31 - 45 years age group was the most represented, with 40.9% of the study population. A risk factor was found in only 5 (3.8%) of patients. Clinical manifestations were recorded in only 27 (20.45%) patients, with fatigue being the commonest (10.6%). Almost all patients (128, 96.9%) have performed the karyotype while 22 (16.7%) have performed fluorescence in situ hybridization (FISH) and 4 (3.0%) the PCR. At diagnosis, 66% of the patients were in the chronic phase (CP), 11.3% in accelerated phase (AP), and 22.7% in blast crisis (BC). All patients presented hyperleukocytosis, with a white blood cell mean of 128,362/mm3. Anemia was common (77.3%), usually moderate (61.4%). Thrombocytopenia was rare (8.3%), as far as basophilia (1.2%). Among those patients, mean values of creatinine, Glutamic pyruvate transaminase (GPT) and glycemia were normal while activated partial thromboplastin time (APTT), prothrombin time (PT), plasma uric acid level, gamma glutamic transferase (GGT), lactate dehydrogenase (LDH), and inflammatory paramete

关键词： Chronic Myeloid Leukemia Biological Clues at Diagnosis Sub-Saharan Africa

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：